Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $72.5400 (-4.45%) ($72.2800 - $74.1700) on Tue. Aug. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.1% (three month average) | RSI | 44 | Latest Price | $72.5400(-4.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -1.4% a day on average for past five trading days. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) QQQ(19%) SKYY(18%) TBT(18%) XAR(18%) IWC(17%) | Factors Impacting SONN price | SONN will decline at least -4.55% in a week (0% probabilities). VCSH(-28%) LQD(-22%) TLT(-20%) CEMB(-16%) VCIT(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.55% (StdDev 9.1%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
1 - 5 Day Possible Target | $69.31(-4.45%) | Resistance Level | $76.29 | 5 Day Moving Average | $74.54(-2.68%) | 10 Day Moving Average | $75.79(-4.29%) | 20 Day Moving Average | $76.29(-4.92%) | To recent high | -43.1% | To recent low | 10.5% | Market Cap | $667m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |